Eicosapentaenoic Acid in Myelinogenesis: Prospective in Multiple Sclerosis Treatment

A. Di Biase, L. Attorri, R. Di Benedetto, S. Salvati

Research output: Chapter in Book/Report/Conference proceedingChapter


There is evidence that increased intake of fish oil, rich in long-chain n-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may beneficially affect the development and course of multiple sclerosis. However, controlled trials have not been able to draw definitive conclusions. The conflicting results could be due to the different mixture of EPA and DHA present in different sources of fish oils used in the clinical trials. In fact, among n-3 polyunsaturated fatty acids, EPA has the most potent effect on myelinogenesis and inflammatory process. The purpose of this chapter is to review the current knowledge on mechanisms underlying these beneficial effects and the evidence of neurological benefits of EPA, looking specifically at multiple sclerosis.

Original languageEnglish
Title of host publicationNutrition and Lifestyle in Neurological Autoimmune Diseases
Subtitle of host publicationMultiple Sclerosis
PublisherElsevier Inc.
Number of pages7
ISBN (Electronic)9780128054444
ISBN (Print)9780128052983
Publication statusPublished - Jan 18 2017


  • Docosahexaenoic acid
  • Eicosapentaenoic acid
  • Fish oil
  • Multiple sclerosis
  • Myelin repair
  • N-3 Polyunsaturated fatty acids

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Eicosapentaenoic Acid in Myelinogenesis: Prospective in Multiple Sclerosis Treatment'. Together they form a unique fingerprint.

Cite this